Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-001302
Filing Date
2024-08-19
Accepted
2024-08-19 09:22:11
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 674855
2 CERTIFICATION bdpt_ex311.htm EX-31.1 8733
3 CERTIFICATION bdpt_ex312.htm EX-31.2 10902
4 CERTIFICATION bdpt_ex321.htm EX-32.1 3550
5 CERTIFICATION bdpt_ex322.htm EX-32.2 3627
11 bdpt_10qimg1.jpg GRAPHIC 3832
  Complete submission text file 0001640334-24-001302.txt   3213813

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20240630.xsd EX-101.SCH 34970
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20240630_lab.xml EX-101.LAB 198315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20240630_cal.xml EX-101.CAL 35578
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20240630_pre.xml EX-101.PRE 169591
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20240630_def.xml EX-101.DEF 98714
61 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 370691
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 241218460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)